Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-19

FDA Approved: LEVOTHYROXINE SODIUM — Original Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved an original application for Levothyroxine Sodium from Accord Healthcare Inc. as a generic thyroid hormone replacement product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVOTHYROXINE SODIUM (levothyroxine sodium)

Snippet

ORIG AP for LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)